Established in 1987, Dr. M.L. Dhawale Memorial Trust (MLDT), registered under the Mumbai Charity Commissioner, has always been caring for the marginalized populace in the community.
It started its journey with one rural clinic to a spread of 6 centers, 5 hospitals. 10 urban clinics, 16 rural clinics, and 4 Mobile Medical Units.
MLDT’s footprint reaches out to over 2 lakh patients every year.
The Rural Homeopathic Hospital at Palghar was established in the year 2000 for the much-needed medical care of the tribal population.
In the recent pandemic times, this hospital as advised by the district authorities was converted as COVID-19 unit while continuing its services to non-COVID patients. In the absence of a fully functional ICU in Palghar, Rural Homeopathic Hospital dedicated its 50% of the bed strength including ICU for treatment of COVID-19 patients. Palghar Rural area is adding 150-200 new COVID cases per day out of which 15% need hospitalization for moderate and severe conditions.
With the lack of testing facilities and labs for a specialized investigation like RTPCR, COVID antibody test, Inflammatory markers in the district of Palghar, the samples need to be sent to the Mumbai Suburban area for testing. The results of these tests take anywhere between 3-4 days to reach the hospital which in turn increases the bed occupancy rate.
In order to improve the prognosis, reduce the bed occupancy rate, and provide faster treatment the trust intends to procure a Protein Analyser – Mispa i3 Automated Cartridge-based Specific Protein Analyzer equipment. This equipment is capable of doing Specific Protein and HbA1C assay test which are currently being done for COVID and otherwise can be used for other tests also for e.g. Diabetes Mellitus, Rheumatoid Arthritis.
The Trust has identified a competent vendor – Agappe Diagnostics Ltd. an ISO 13485: 2016 & 9001: 2015 certified company for supplying the equipment and the cost is INR 2,00,600 (Rupees Two Lakh Six Hundred Only) inclusive of taxes.
The Trust humbly appeals for your support to procure the equipment which will enable it to conduct the tests immediately for early prognosis and prompt treatment of the economically weaker populace on a subsidized rate and even free of cost for the extremely poor who cannot afford medical costs.